Investment Rating - The investment rating for the company is "Outperform the Market" [6] Core Views - The company has shown effective business transformation, achieving a 6.9% year-on-year growth in net profit attributable to shareholders, reaching 40.93 billion yuan in the first half of 2025. Total premium income reached 525.09 billion yuan, a 7.3% increase year-on-year, marking the best performance for the same period in history [1] - The company has significantly improved its new business value, which rose to 28.55 billion yuan, reflecting a 20.3% year-on-year increase, maintaining its leading position in the industry [1] - The company has diversified its product offerings, with the proportion of floating income products increasing, leading to a notable improvement in value rates [2] - The company has made significant progress in channel transformation, with the bancassurance channel showing a remarkable growth of 45.7% year-on-year [3] - The company has enhanced its investment strategy, increasing the allocation of equity assets, resulting in a 4.2% year-on-year increase in total investment income [3] Summary by Sections Financial Performance - In the first half of 2025, the company achieved a total premium income of 525.09 billion yuan, a 7.3% increase year-on-year, and a net profit of 40.93 billion yuan, also up by 6.9% year-on-year [1] - The new business value reached 28.55 billion yuan, with a year-on-year growth of 20.3% [1] Product and Channel Development - The company has balanced its product structure with new single premium income from life insurance, annuity insurance, and health insurance accounting for 30.32%, 32.01%, and 33.42% respectively [2] - The bancassurance channel achieved a total premium of 72.44 billion yuan, with a year-on-year growth of 45.7% [3] Investment Strategy - The company has increased its equity asset allocation, with net investment income reaching 96.07 billion yuan and a net investment yield of 2.78% [3] - The total investment income was 127.51 billion yuan, with a total investment yield of 3.29% [3] Earnings Forecast - The company is expected to have an EPS of 3.83, 3.88, and 3.94 yuan per share for 2025, 2026, and 2027 respectively, with a current P/EV of 0.81, 0.75, and 0.68 for the same years [4][5]
中国人寿(601628):业务转型显效,价值稳健增长